全文获取类型
收费全文 | 4196474篇 |
免费 | 312780篇 |
国内免费 | 9866篇 |
专业分类
耳鼻咽喉 | 58073篇 |
儿科学 | 138081篇 |
妇产科学 | 115496篇 |
基础医学 | 589526篇 |
口腔科学 | 122041篇 |
临床医学 | 385703篇 |
内科学 | 809229篇 |
皮肤病学 | 94297篇 |
神经病学 | 345275篇 |
特种医学 | 163100篇 |
外国民族医学 | 1328篇 |
外科学 | 626049篇 |
综合类 | 97622篇 |
现状与发展 | 6篇 |
一般理论 | 1754篇 |
预防医学 | 337095篇 |
眼科学 | 96173篇 |
药学 | 310076篇 |
14篇 | |
中国医学 | 8028篇 |
肿瘤学 | 220154篇 |
出版年
2018年 | 44268篇 |
2017年 | 34110篇 |
2016年 | 39002篇 |
2015年 | 44286篇 |
2014年 | 61469篇 |
2013年 | 93918篇 |
2012年 | 124355篇 |
2011年 | 132195篇 |
2010年 | 79483篇 |
2009年 | 75684篇 |
2008年 | 123776篇 |
2007年 | 131779篇 |
2006年 | 133507篇 |
2005年 | 129170篇 |
2004年 | 125216篇 |
2003年 | 120375篇 |
2002年 | 116529篇 |
2001年 | 191876篇 |
2000年 | 197318篇 |
1999年 | 166771篇 |
1998年 | 49480篇 |
1997年 | 43910篇 |
1996年 | 44019篇 |
1995年 | 42691篇 |
1994年 | 39601篇 |
1993年 | 37251篇 |
1992年 | 133652篇 |
1991年 | 130176篇 |
1990年 | 126361篇 |
1989年 | 122179篇 |
1988年 | 112992篇 |
1987年 | 111163篇 |
1986年 | 105176篇 |
1985年 | 101076篇 |
1984年 | 76136篇 |
1983年 | 65051篇 |
1982年 | 38966篇 |
1981年 | 35066篇 |
1979年 | 70323篇 |
1978年 | 49887篇 |
1977年 | 42240篇 |
1976年 | 39487篇 |
1975年 | 42230篇 |
1974年 | 50778篇 |
1973年 | 48570篇 |
1972年 | 45452篇 |
1971年 | 42485篇 |
1970年 | 39178篇 |
1969年 | 37307篇 |
1968年 | 34179篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Abhinav Sharma Adrian Coles Nishant K. Sekaran Neha J. Pagidipati Michael T. Lu Daniel B. Mark Kerry L. Lee Hussein R. Al-Khalidi Udo Hoffmann Pamela S. Douglas 《Journal of the American College of Cardiology》2019,73(8):893-902
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献22.
23.
F. Murina R. Felice S. Di Francesco L. Nelvastellio I. Cetin 《Gynecological endocrinology》2020,36(5):431-435
AbstractThis study is a single-center, retrospective analysis of postmenopausal women presenting with dyspareunia and vulvar pain, aiming to evaluate relative effectiveness of vestibular CO2 laser therapy as a treatment. Three monthly sessions of laser were performed to each patient and thereafter a three-months follow-up was stablished. A total number of 72 patients undergoing vestibular laser treatment were recruited from patient files in the period between 2016 and 2018. Among these, 39 women also received a concomitant treatment with ospemifene (60?mg/day) during the study period. There was a statistically significant reduction of all the symptoms in both groups up to the three month follow-up. Regarding dryness and dyspareunia, the relief tent to be more prominent in the ospemifene?+?laser group at all follow-ups and remained statistically significant at three-month follow-up. Specifically, vestibular dryness was significantly lower in the ospemifene?+?laser group compared with the laser treatment group (?87% vs???34%, respectively), and the vestibular health score started declining faster in the ospemifene?+?laser group. Although, additional research is needed to understand the mechanism of action, our data shows that a combination regimen of laser and ospemifene may improve clinical effectiveness for long-term treatment of symptoms associated with the under-recognized genitourinary syndrome of menopause. 相似文献
24.
25.
26.
27.
28.
29.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献30.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168